MedPath

Superiority Randomized Controlled Trial of Ultrasound-guided PENG Block Compared to Surgical Infiltration in the Analgesia of Posterior Total Hip Arthroplasty Surgery

Not Applicable
Recruiting
Conditions
Hip Arthropathy
Hip Arthrosis
Interventions
Procedure: PENG Block ultrasound-guided
Procedure: Surgical infiltration
Registration Number
NCT06257160
Lead Sponsor
CHU de Reims
Brief Summary

Pain after total hip replacement (THR) surgery is severe. The target population is elderly and comorbid. Level III analgesics are responsible for significant side effects in this population. Locoregional analgesia, by reducing the consumption of painkillers, is an effective way of reducing morphine or morphine agonist consumption in this surgery. Furthermore, these techniques fit in perfectly with the objectives of accelerated rehabilitation after surgery. Surgical infiltration is a frequently used and effective analgesic technique. PENG block is a new locoregional anesthesia technique which initial results show promising analgesic efficacy and the absence of loss of strength through motor block.

In February 2022, we carried out a survey of national anesthetic practices in posterior hip arthroplasty, with the help of the SFAR (Société Française d'Anesthésie-Réanimation).

It shows that, despite the lack of plentiful literature on the subject, the PENG block is currently the most frequently performed pre-operative block in hip arthroplasty (PENG block in 39.5% of cases, femoral block in 13% of cases).

The survey also shows that in 41.5% of cases, no block is performed, and only intraoperative surgical infiltration is carried out.

PENG block and surgical infiltration are therefore the two analgesic techniques most frequently used in France today.

It is for these reasons that we feel it is essential to carry out a study comparing these two techniques.

Detailed Description

The aim of this study was to compare the clinical efficacy of these two locoregional analgesia strategies in posterior total hip replacement surgery: ultrasound-guided PENG block and surgical infiltration.

The study is a superiority randomized, double-blind (patient and evaluator will be blinded to the randomization group), single-center trial.

Two groups of patients will be compared: a group of patients benefiting from the echo-guided PENG block strategy, and a group of patients benefiting from intraoperative surgical infiltration.

The type of treatment (PENG block or surgical infiltration) will be randomized. The target population concerns patients scheduled for posterior total hip replacement surgery at Reims University Hospital If the hypothesis of the superior efficacy of echo-guided block PENG is confirmed, our analgesia strategy for total hip replacement surgery will be modified, enabling us to offer the most effective locoregional analgesia technique and thus reduce the morbidity and mortality associated with morphine consumption.

This could have both a medical and an economic impact, by optimizing post-operative monitoring and convalescence for these patients.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
194
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PENG Block ultrasound-guidedPENG Block ultrasound-guided-
Surgical infiltrationSurgical infiltration-
Primary Outcome Measures
NameTimeMethod
Morphine consumptionAt 24 hours postoperative
Secondary Outcome Measures
NameTimeMethod
Need for analgesia rescue techniqueAt 24 hours postoperative
10 meters walk testAt 24 hours postoperative
Muscle strength testAt 24 hours postoperative
Pain evaluationAt 48 hours postoperative

Numeric pain intensity scale

Success or failure at first stand up testAt 4 hours postoperative
Adverse events due to PENG block ou surgical infiltrationAt 24 hours postoperative
Length of hospital stayAt the end of the stay
Adverse events due to consumption of morphineAt 24 hours postoperative

Trial Locations

Locations (1)

Damien JOLLY

🇫🇷

Reims, France

© Copyright 2025. All Rights Reserved by MedPath